ITB vs VHT
iShares US Home Construction ETF vs Vanguard Health Care ETF
- • VHT has the lower expense ratio at 0.09% vs 0.38% for ITB.
- • VHT pays a higher dividend yield (1.58%).
Side-by-side metrics
| Metric | ITB | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.38% | 0.09% |
Dividend yield Trailing 12-month yield. | 0.62% | 1.58% |
AUM Assets under management — bigger funds are typically more liquid. | $2.60B | $20.39B |
YTD return | -0.05% | 7.21% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.48 | 0.57 |
P/E ratio | 15.93 | 26.41 |
Last price | $97.50 | $305.90 |
Inception | — | — |
Issuer | iShares | Vanguard |
ITB top holdings
| DHI | D.R. Horton Inc | 15.77% |
| PHM | PulteGroup Inc | 9.60% |
| LEN | Lennar Corp Class A | 7.15% |
| NVR | NVR Inc | 6.76% |
| TOL | Toll Brothers Inc | 5.05% |
| SHW | Sherwin-Williams Co | 4.55% |
| HD | The Home Depot Inc | 4.44% |
| LOW | Lowe's Companies Inc | 4.10% |
| LII | Lennox International Inc | 3.35% |
| MAS | Masco Corp | 3.03% |
VHT top holdings
| LLY | Eli Lilly and Co | 13.99% |
| JNJ | Johnson & Johnson | 8.44% |
| ABBV | AbbVie Inc | 6.07% |
| UNH | UnitedHealth Group Inc | 5.44% |
| MRK | Merck & Co Inc | 4.63% |
| TMO | Thermo Fisher Scientific Inc | 2.88% |
| AMGN | Amgen Inc | 2.86% |
| GILD | Gilead Sciences Inc | 2.63% |
| ISRG | Intuitive Surgical Inc | 2.38% |
| ABT | Abbott Laboratories | 2.35% |
About ITB
ITB (iShares US Home Construction ETF) is US homebuilding and construction companies. Managed by iShares, the fund carries $2.6B in assets under management, an expense ratio of 0.38%, a dividend yield of 0.62%. Its largest holding is D.R. Horton Inc (DHI), which represents 15.8% of the portfolio. Real Estate is the fund's largest sector exposure at 0.7%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $20.4B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.58%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.0% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.